search
Back to results

NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management

Primary Purpose

Acute Pain Due to Trauma

Status
Completed
Phase
Phase 3
Locations
Tunisia
Study Type
Interventional
Intervention
Paracetamol
NSAID
paracetamol-NSAID
Sponsored by
University of Monastir
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain Due to Trauma focused on measuring acute pain, trauma, paracetamol, NSAID

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 18 years or older
  • acute (<24 hours) post traumatic pain of the extremity and requiring analgesic treatment upon discharge for pain with intensity >3 on a visual numeric scale

Exclusion criteria:

  • open fracture
  • head, abdominal, thoracic or polytrauma.
  • Need for hospitalization, regular use of paracetamol and NSAIDs during the two weeks before admission to ED
  • history of allergy or hypersensitivity to either paracetamol or NSAIDs,
  • contraindication to paracetamol or NSAIDs,
  • acute /history of GI hemorrhage and renal insufficiency,
  • an inability to assess pain intensity according to the VNS.
  • Pregnancy
  • heart failure
  • known hepatic cirrhosis
  • known severe renal impairment (Creatinine clearance <30 ml/min)
  • swallowing disorders
  • Refusal, incapacity or difficulties to consent or to communicate

Sites / Locations

  • Monastir University Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Parcetamol Group

NSAID Group

NSAID + Paracetamol Group

Arm Description

The patient receives an envelope containing Paracetamol 1000 mg at the dose of 3 times / day + follow-up sheet + appointment card.

The patient receives an envelope containing NSAID 20 mg piroxicam twice daily / day + follow-up sheet + appointment card.

The patient receives an envelope containing NSAID 20 mg piroxicam at a dose of 2 times/day + Paracetamol 1000 mg at a dose of 3 times / day + follow-up sheet + appointment card.

Outcomes

Primary Outcome Measures

new oral analgesic medications needed rate
oral analgesic medications other than those of the protocol prescribed by the treating physicians or taken by patients' own volition

Secondary Outcome Measures

the between-group difference in mean change in VNS score measured from ED discharge (VNS D0) to 7 days later
[delta VNS= (VNS D0 - VNS D7 / VNS D0) x 100]
The appearance of side effects
The appearance of side effects: such as Drowsiness ,Decreased respiratory rate (<14 c / min), Cutaneous rash, Vomiting,Nausea,pruritus, Dizziness. • Digestive hemorrhage.
the rate of ED readmissions for residual pain
ED readmissions for residual pain
patient satisfaction assessed by Likert's verbal scale.
patient satisfaction assessed by Likert's verbal scale.

Full Information

First Posted
May 14, 2017
Last Updated
September 29, 2020
Sponsor
University of Monastir
search

1. Study Identification

Unique Protocol Identification Number
NCT03222518
Brief Title
NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management
Official Title
NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
March 1, 2017 (Actual)
Primary Completion Date
November 1, 2018 (Actual)
Study Completion Date
November 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Monastir

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to: Compare the effect of paracetamol alone against NSAIDs alone against the association of paracetamol + NSAIDs in the treatment of traumatic pain.
Detailed Description
Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain. All patients were assigned in a 1:1:1 ratio. Randomization of subjects was performed centrally according to a computer-generated random code provided by one of investigators who was not involved in any other part of the trial. The patients included were divided into 3 groups: Paracetamol group who received paracetamol 1000 mg orally every 8th hour for 7 days; NSAID group who received piroxicam 20 mg orally twice a day for 7 days, and Paracetamol-NSAID combination who received both treatments at the same doses for 7 days. All protocol treatments were administered in opaque packets with code number according to the randomization list by an independent nurse who was not involved in monitoring or follow-up of the individuals. Data were collected for each patient, including demographics, medical history, and findings of the clinical examination. Injury Severity Score (ISS) whose values range from 0 to 75 was also assessed. Each patient was re-evaluated on the 3rd and 7th day post-trauma (D7) using a telephone contact by a clinical research associates who was blinded to the details of the study to note the following clinical data: pain VNS, ED readmissions for residual pain, need for other analgesics other than those of the protocol, other treatment modalities the patient might have used (adherence to the treatment prescribed), and side effects. In addition patients were asked about their satisfaction with pain control following ED using five point Likert scale: very dissatisfied, not satisfied, neutral, satisfied and very satisfied and about the degree to which they adhered to medication schedule. The principal investigator who was aware of the allocation was not involved in monitoring or recording of the outcomes until the data collection was completed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Pain Due to Trauma
Keywords
acute pain, trauma, paracetamol, NSAID

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Subjects are randomized in 3 arms: paracetamol group NSAID group paracetamol + NSAID group
Masking
ParticipantOutcomes Assessor
Masking Description
study medications consists of identical shape pills of each study medication randomization is made by sealed envelops and a randomly sequence generated numbers. patients and the research associate who collected the outcome data are blinded from the study group
Allocation
Randomized
Enrollment
1500 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Parcetamol Group
Arm Type
Active Comparator
Arm Description
The patient receives an envelope containing Paracetamol 1000 mg at the dose of 3 times / day + follow-up sheet + appointment card.
Arm Title
NSAID Group
Arm Type
Active Comparator
Arm Description
The patient receives an envelope containing NSAID 20 mg piroxicam twice daily / day + follow-up sheet + appointment card.
Arm Title
NSAID + Paracetamol Group
Arm Type
Active Comparator
Arm Description
The patient receives an envelope containing NSAID 20 mg piroxicam at a dose of 2 times/day + Paracetamol 1000 mg at a dose of 3 times / day + follow-up sheet + appointment card.
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Intervention Description
21 pills of Paracetamol 1000mg are provided with a preconised dose of 1 pill 3 times per day over 7 days period
Intervention Type
Drug
Intervention Name(s)
NSAID
Other Intervention Name(s)
piroxicam
Intervention Description
14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Intervention Type
Drug
Intervention Name(s)
paracetamol-NSAID
Other Intervention Name(s)
combination
Intervention Description
21 identical pills of paracetamol ith a preconised dose of 1 pill 3 times per day over 7 days period+14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Primary Outcome Measure Information:
Title
new oral analgesic medications needed rate
Description
oral analgesic medications other than those of the protocol prescribed by the treating physicians or taken by patients' own volition
Time Frame
3 days and 7 days
Secondary Outcome Measure Information:
Title
the between-group difference in mean change in VNS score measured from ED discharge (VNS D0) to 7 days later
Description
[delta VNS= (VNS D0 - VNS D7 / VNS D0) x 100]
Time Frame
3 and 7 days
Title
The appearance of side effects
Description
The appearance of side effects: such as Drowsiness ,Decreased respiratory rate (<14 c / min), Cutaneous rash, Vomiting,Nausea,pruritus, Dizziness. • Digestive hemorrhage.
Time Frame
7 days
Title
the rate of ED readmissions for residual pain
Description
ED readmissions for residual pain
Time Frame
3 and 7 days
Title
patient satisfaction assessed by Likert's verbal scale.
Description
patient satisfaction assessed by Likert's verbal scale.
Time Frame
3 and 7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 18 years or older acute (<24 hours) post traumatic pain of the extremity and requiring analgesic treatment upon discharge for pain with intensity >3 on a visual numeric scale Exclusion criteria: open fracture head, abdominal, thoracic or polytrauma. Need for hospitalization, regular use of paracetamol and NSAIDs during the two weeks before admission to ED history of allergy or hypersensitivity to either paracetamol or NSAIDs, contraindication to paracetamol or NSAIDs, acute /history of GI hemorrhage and renal insufficiency, an inability to assess pain intensity according to the VNS. Pregnancy heart failure known hepatic cirrhosis known severe renal impairment (Creatinine clearance <30 ml/min) swallowing disorders Refusal, incapacity or difficulties to consent or to communicate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Semir Nouira, MD
Organizational Affiliation
University of Monastir
Official's Role
Principal Investigator
Facility Information:
Facility Name
Monastir University Hospital
City
Monastir
ZIP/Postal Code
5000
Country
Tunisia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management

We'll reach out to this number within 24 hrs